Skip to main content

Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups.

Publication ,  Journal Article
Bayliss, EA; Goodrich, GK; Barrow, JC; Harding, B; Ripley, CA; Kraus, CR; Paolino, V; Norton, JD; Sheehan, OC; Weffald, LA; Green, AR ...
Published in: Pharmacoepidemiol Drug Saf
April 2025

PURPOSE: Accurately identifying medication discontinuations at scale is important for developing evidence about deprescribing. Gaps in dispensing often serve as proxies for discontinuation but are imprecise. We categorize reasons for gaps in dispensing to inform data-based methods to accurately identify medication discontinuations. METHODS: Using pharmacy dispensing data, we purposively sampled from a population of adults age 65+ with 2+ chronic conditions who experienced a 90-day gap in dispensing-with and without subsequent fills-of oral diabetes drugs, statins, proton pump inhibitors, drugs with anticholinergic properties, anticoagulants and antiplatelet drugs, or antihypertensives. We reviewed clinical documentation (e.g., visit notes, communications, medication orders) from last dispensing through the 90-day gap plus 120 days to classify dispensing gaps as true discontinuations (clinically intended) or non-discontinuations (no evidence of intent to discontinue), and then into subcategories. Medications with no documented explanation for the gap in dispensing and continued listing on the patient's medication list were classified as non-discontinuations. RESULTS: Of N = 1906 records reviewed, there were 1068 (56%) true discontinuations and 838 (44%) non-discontinuations. Subcategories within true discontinuations included provider intent to discontinue, provider substitutions, intentional stops followed by restarts, and agreeing with a colleague's or patient's decision to discontinue. Non-discontinuations included documented low adherence, changes in dose, changes in pharmacy formulary, and changes in drug formulation. Proportions of drugs in categories and subcategories varied by medication group. CONCLUSION: Using gaps in dispensing as proxy measures for medication discontinuation may introduce bias through misclassification, and varied reasons for discontinuation may complicate causal interpretations.

Duke Scholars

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

April 2025

Volume

34

Issue

4

Start / End Page

e70142

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Male
  • Humans
  • Female
  • Deprescriptions
  • Aged, 80 and over
  • Aged
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bayliss, E. A., Goodrich, G. K., Barrow, J. C., Harding, B., Ripley, C. A., Kraus, C. R., … Boyd, C. M. (2025). Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups. Pharmacoepidemiol Drug Saf, 34(4), e70142. https://doi.org/10.1002/pds.70142
Bayliss, Elizabeth A., Glenn K. Goodrich, Jennifer C. Barrow, Bill Harding, Courtney A. Ripley, Courtney R. Kraus, Valerie Paolino, et al. “Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups.Pharmacoepidemiol Drug Saf 34, no. 4 (April 2025): e70142. https://doi.org/10.1002/pds.70142.
Bayliss EA, Goodrich GK, Barrow JC, Harding B, Ripley CA, Kraus CR, et al. Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups. Pharmacoepidemiol Drug Saf. 2025 Apr;34(4):e70142.
Bayliss, Elizabeth A., et al. “Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups.Pharmacoepidemiol Drug Saf, vol. 34, no. 4, Apr. 2025, p. e70142. Pubmed, doi:10.1002/pds.70142.
Bayliss EA, Goodrich GK, Barrow JC, Harding B, Ripley CA, Kraus CR, Paolino V, Norton JD, Sheehan OC, Weffald LA, Green AR, Palen TE, Reeve E, Maciejewski ML, Boyd CM. Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups. Pharmacoepidemiol Drug Saf. 2025 Apr;34(4):e70142.

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

April 2025

Volume

34

Issue

4

Start / End Page

e70142

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Male
  • Humans
  • Female
  • Deprescriptions
  • Aged, 80 and over
  • Aged
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services